<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161453">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01903395</url>
  </required_header>
  <id_info>
    <org_study_id>NKP332-032</org_study_id>
    <nct_id>NCT01903395</nct_id>
  </id_info>
  <brief_title>Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer</brief_title>
  <acronym>FAMKOL</acronym>
  <official_title>Nurse-led Colon Cancer Risk Counseling for First-degree Relatives to Enhance Use of Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martin-Luther-Universität Halle-Wittenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Martin-Luther-Universität Halle-Wittenberg</source>
  <oversight_info>
    <authority>Germany: Federal Ministry of Education and Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      BACKGROUND: First-degree relatives of patients with colorectal cancer are at increased risk
      for colorectal cancer as well. Nevertheless, participation in the German national screening
      program stagnates at 2-3 percent per year even in this high-risk population.

      AIM: The study is aimed to increase the portion of the first-degree relatives on 50% which
      take up a preventive colonoscopy.

      METHODS: Cluster-randomized controlled multi-center trial. Study sites (clusters) are mainly
      certified cancer centers and office-based gastroenterologists from all over Germany.
      Index-patients with colorectal cancer of different stages are asked to hand over the study
      material to their relatives, consisting of an invitation to a nurse-led counseling on
      preventive colonoscopy and an one-to-one appointment with a clinical expert of one of the
      study sites next.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>utilization of preventive colonoscopy</measure>
    <time_frame>utilization within 30 days after enrolement</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of advanced adenomas or carcinomas in situ</measure>
    <time_frame>Rate within 6 month after enrolement</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative complications associated with the colonoscopy</measure>
    <time_frame>within 30 days after enrolement</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>barriers to the use of preventive colonoscopy</measure>
    <time_frame>within 30 day after enrolement, additional at 6 months after enrolement</time_frame>
    <safety_issue>No</safety_issue>
    <description>Barriers against preventive colonoscopy are very common among the healthy population. Such barriers can bei either of cognitive (e.g. being afraid of the potential diagnosis) or emotional nature (e.g. shame to be exposed naked to the examiners).
Barriers are assessed by Barriers Questionnaire-II (BQ-II) during telephone counselling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effectiveness and cost-effectiveness of nurse-led counselling</measure>
    <time_frame>within 30 days after enrolement</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time delay between signed informed consent and utilization of colonoscopy</measure>
    <time_frame>at utilization of the colonoscopy</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">492</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Nurse-led counselling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First-degree relatives of patients undergoing active treatment for colorectal cancer are offered a nurse-led counselling by telephone regarding emotional and cognitive barriers to screening utilization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual print media, offered standardly by the recruiting centres.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nurse-led counselling</intervention_name>
    <description>Nurse-led telephone counselling to double the utilization of preventive colonoscopy</description>
    <arm_group_label>Nurse-led counselling</arm_group_label>
    <other_name>n.a.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 18 and over

          -  being first-degree relatives of patients with diagnosed colorectal cancer

          -  able to understand German

        Exclusion Criteria:

          -  Familial Adenomatous Polyposis

          -  utilization of diagnostic colonoscopy within the past 5 years

          -  being ever treated for colorectal cancer

          -  actual inflammatory bowl disease

          -  comorbidities associated with reduced further life expectancy (ECOG performance
             status &gt;3
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Bauer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Martin-Luther-University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Bauer, PhD</last_name>
    <phone>+49 345 557-4124</phone>
    <email>alexander.bauer@medizin.uni-halle.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margarete Landenberger, Prof., PhD</last_name>
    <phone>+49 345 557-1220</phone>
    <email>margarete.landenberger@medizin.uni-halle.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <state>Baden-Würtemberg</state>
        <zip>71640</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Diakoniekrankenhaus Mannheim</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Würtemberg</state>
        <zip>68163</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dieter Schilling, Prof., PhD</last_name>
      <phone>0621 8102-3405</phone>
      <email>d.schilling@diako-ma.de</email>
    </contact>
    <investigator>
      <last_name>Dieter Schilling, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Stuttgart Krankenhaus Bad Cannstatt</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-Würtemberg</state>
        <zip>70374</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tilo Andus, Prof., PhD</last_name>
      <phone>0711-2786-2401</phone>
      <email>tandus@klinikum-stuttgart.de</email>
    </contact>
    <investigator>
      <last_name>Tilo Andus, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Baden-Würtemberg</state>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <state>Bayern</state>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Fischbach, Prof., PhD</last_name>
      <phone>06021-323010</phone>
      <email>wolfgang.fischbach@klinikum-aschaffenburg.de</email>
    </contact>
    <investigator>
      <last_name>Wolfgang Fischbach, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helmut Neumann, Prof., PhD</last_name>
      <phone>09131 85-45053</phone>
      <email>helmut.neumann@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Helmut Neumann, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum München</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Barnim</name>
      <address>
        <city>Eberswalde</city>
        <state>Brandenburg</state>
        <zip>16225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hemeling, PhD</last_name>
      <phone>03334- 692282</phone>
      <email>gastro-onko@klinikum-barnim.de</email>
    </contact>
    <investigator>
      <last_name>Hemeling, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas M. Gress, Prof., PhD</last_name>
      <phone>06421-58 66460</phone>
      <email>gress@med.uni-marburg.de</email>
    </contact>
    <investigator>
      <last_name>Thomas M. Gress, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <state>Mecklenburg-Vorpommern</state>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Markus Lerch, Prof., PhD</last_name>
      <phone>03834 86-7231</phone>
      <email>lerch@uni-greifswald.de</email>
    </contact>
    <investigator>
      <last_name>Markus Lerch, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Braunschweig</name>
      <address>
        <city>Braunschweig</city>
        <state>Niedersachsen</state>
        <zip>38126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Max Reinshagen, Prof., PhD</last_name>
      <phone>0531 595 2431</phone>
      <email>m.reinshagen@klinikum-braunschweig.de</email>
    </contact>
    <investigator>
      <last_name>Max Reinshagen, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Celle</name>
      <address>
        <city>Celle</city>
        <state>Niedersachsen</state>
        <zip>29223</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Hollerbach, Prof., PhD</last_name>
      <phone>05141-72-1201</phone>
      <email>stephan.hollerbach@akh-celle.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Hollerbach, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Lüneburg</name>
      <address>
        <city>Lüneburg</city>
        <state>Niedersachsen</state>
        <zip>21339</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torsten Kucharzik, Prof., PhD</last_name>
      <phone>04131 /77-2241</phone>
      <email>torsten.kucharzik@klinikum-lueneburg.de</email>
    </contact>
    <investigator>
      <last_name>Torsten Kucharzik, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Osnabrück GmbH</name>
      <address>
        <city>Osnabrück</city>
        <state>Niedersachsen</state>
        <zip>49076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Högemann, Prof., PhD</last_name>
      <phone>0541/405-6301</phone>
      <email>bernhard.hoegemann@klinikum-os.de</email>
    </contact>
    <investigator>
      <last_name>Bernhard Högemann, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johanniter-Krankenhaus Rheinhausen</name>
      <address>
        <city>Duisburg</city>
        <state>Nordrhein-Westfalen</state>
        <zip>47228</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Meyer, PhD</last_name>
      <phone>02065/971201</phone>
      <email>a.meyer@johanniter-rheinhausen.de</email>
    </contact>
    <investigator>
      <last_name>Alexander Meyer, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik Evang. Krankenhaus Kalk</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>51103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Kruis, Prof., PhD</last_name>
      <phone>0221/8289-5289</phone>
      <email>kruis@evkk.de</email>
    </contact>
    <investigator>
      <last_name>W. Kruis, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Köln-Holweide</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>51067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arno Dormann, Prof., PhD</last_name>
      <phone>02 21/8907- 2602</phone>
      <email>dormanna@kliniken-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Arno Dormann, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mühlenkreiskliniken Klinikum Minden</name>
      <address>
        <city>Minden</city>
        <state>Nordrhein-Westfalen</state>
        <zip>32429</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carsten Gartung, Prof., PhD</last_name>
      <phone>0571/790-3001</phone>
      <email>carsten.gartung@klinikum-minden.de</email>
    </contact>
    <investigator>
      <last_name>Carsten Gartung, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Knappschaftskrankenhaus Ruhr Universität Bochum</name>
      <address>
        <city>Bochum</city>
        <state>Nordrhein-Wetsfalen</state>
        <zip>44892</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wolff Schmiegel, Prof., PhD</last_name>
      <phone>0234/299-3401</phone>
      <email>wolff.Schmiegel@rub.de</email>
    </contact>
    <investigator>
      <last_name>Wolf Schmiegel, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus St. Marienwörth</name>
      <address>
        <city>Bad Kreuznach</city>
        <state>Rheinland-Pfalz</state>
        <zip>55543</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Diakonissen-Stiftungs-Krankenhaus Speyer</name>
      <address>
        <city>Speyer</city>
        <state>Rheinland-Pfalz</state>
        <zip>67346</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Rabenstein, Prof., PhD</last_name>
      <phone>06232/22-1883</phone>
      <email>thomas.rabenstein@diakonissen.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Rabenstein, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterologische Schwerpunktpraxis Völklingen</name>
      <address>
        <city>Völklingen</city>
        <state>Saarland</state>
        <zip>66333</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinik Sangerhausen</name>
      <address>
        <city>Sangerhausen</city>
        <state>Sachsen-Anhalt</state>
        <zip>06526</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernd Klinge, PhD</last_name>
      <phone>03464-663500</phone>
      <email>bernd.Klinge@helios.kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Bernd Klinge, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westküstenklinikum Heide</name>
      <address>
        <city>Heide</city>
        <state>Schleswig-Holstein</state>
        <zip>25746</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karin Münzer, PhD</last_name>
      <phone>+49-481-785-701505</phone>
      <email>kmuenzer@wkk-hei.de</email>
    </contact>
    <investigator>
      <last_name>Karin Münzer, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <state>Thüringen</state>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Stallmach, Prof., PhD</last_name>
      <phone>+49 3641 9-324221</phone>
      <email>Andreas.Stallmach@med.uni-jena.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Stallmach, Prof., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 16, 2013</lastchanged_date>
  <firstreceived_date>July 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Martin-Luther-Universität Halle-Wittenberg</investigator_affiliation>
    <investigator_full_name>Alexander Bauer</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Colorectal Neoplasms/*drug therapy/*secondary</keyword>
  <keyword>Health Services Accessibility</keyword>
  <keyword>Humans</keyword>
  <keyword>Supportive Care Needs</keyword>
  <keyword>Psychooncology</keyword>
  <keyword>Primary Health Care/*methods</keyword>
  <keyword>Treatment Outcome</keyword>
  <keyword>Socioeconomic Factors</keyword>
  <keyword>Quality Assurance, Health Care</keyword>
  <keyword>Adult</keyword>
  <keyword>Aged</keyword>
  <keyword>Aged, 80 and over</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
